Corporate DisclosureBEACONPHAR
BEACONPHAR Corporate Disclosure — 19 May 2021
Announcement summary
- What happened
- BEACONPHAR published a corporate disclosure on 19 May 2021. Read the full announcement for details.
- Company
- Beacon Pharmaceuticals PLC
- Announcement published
Original announcement
(Q3 Un-audited): The Company has further informed that the turnover of the Company for the period July 2020 to March 2021 has been increased by 50% from the corresponding period of previous year. On the other hand, total Operating Expenses has been increased by only 9.60% from the corresponding period of previous year. Due to drastic increase of turnover and decrease of Operating expenses for the nine month period from July 2020 to March 2021 the EPS has been increased.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b0000400537f0
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BEACONPHAR
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.